FDA Investigator: Tiara N. Brown-Crosen
- Tiara N. Brown-Crosen first started conducting FDA inspections in 2015, with the last inspection in 2019. Over that time, Tiara N. Brown-Crosen has conducted 50 inspections at 47 companies across 50 sites.
Get Tiara Brown-Crosen's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Sentio Biosciences, Maryland Heights | April 2019
Available Now - $199
Tiara N. Brown-Crosen
Animal Drugs & Feed Form 483
FDA 483 Lee Pharma, Gaddipotharam | November 2018
Available Now - $199
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 HomeChoice Partners, . dba Bioscrip Infusion | 2018
Available Now - $199
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Biotika a.s, Slovenska Lupca | June 2018
Available Now - $199
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 SSM Health Care St. Louis DBA SSM St. Clare H | 2017
Available Now - $199
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Central Illinois Compounding, dba Preckshot | 2017
Available Now - $199
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Vi-jon, Saint Louis | January 2017
Available Now - $199
Tiara N. Brown-Crosen
Human Drug Form 483
FDA EIR Mallinckrodt, Saint Louis | November 2016
Available Now - $995
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Camco Chemical, Florence | December 2015
Available Now - $199
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Tapi Puerto Rico, Guayama | November 2015
Available Now - $199
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Reliance Life Sciences, Navi Mumbai | 2019
Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Bal Pharma Limited- Unit 2, Bangalore | 2018
Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Wuhan Biocause Pharmaceutical Development Co., Ltd., Wuhan | 2018
Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Fujian Kerui Pharmaceutical Co., Ltd., Fuqing | 2018
Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Prevention Health Sciences Inc., Raleigh | 2018
Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Sanofi - Aventis US LLC, Saint Louis | 2017
Out-of-stock
Tiara N. Brown-Crosen
Animal Drugs & Feed Form 483
FDA 483 Delille Oxygen Company, Columbus | 2017
Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Alcami Corporation, Affton | 2017
Out-of-stock
Tiara N. Brown-Crosen
Animal Drugs & Feed Form 483
FDA 483 Patheon Italia S.p.A., Ferentino | 2017
Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 Fresenius Kabi AB, Uppsala | 2017
Out-of-stock
Tiara N. Brown-Crosen
Animal Drugs & Feed Form 483
FDA 483 Alkem Laboratories Ltd, Daman | 2016
Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483
FDA 483 O'Neal Scientific Services Inc, Saint Louis | 2016
Out-of-stock
Tiara N. Brown-Crosen
Animal Drugs & Feed Form 483
FDA 483 Mallinckrodt Inc., Greenville | 2016
Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483
Co-Investigators (20)
- Maria J. Lopez- Barragan, FDA Investigator
- V Ashutosh Rao, FDA Investigator
- Frances Namuswe, FDA Investigator
- Lopez- Barragan, Maria J, FDA Investigator
- Robert J. Ham, FDA Investigator
- Shanna R. Haden, FDA Investigator
- Aditi Thakur, FDA Investigator
- Steven P. Donald, FDA Investigator
- Cheryl A. Clausen, FDA Investigator
- Dewayne E. Whitlock, FDA Investigator
- Janna C. Hutchinson, FDA Investigator
- Lindsey M. Schwierjohann, FDA Investigator
- Jose A. Cruz Gonzalez, FDA Investigator
- Cruz Gonzalez, Jose A, FDA Investigator
- Steven P. Allen, FDA Investigator
- Dwight D. Ferguson, FDA Investigator
- Joseph R. Lambert, FDA Investigator
- Michele Perry-Williams, FDA Investigator
- Michele Perry Williams, FDA Investigator
- Valeria A. Moore, FDA Investigator